Skip to main navigation Skip to search Skip to main content

FOXP3+ Regulatory T Cells Use Heparanase To Access IL-2 Bound to ECM in Inflamed Tissues

  • Hunter A. Martinez
  • , Ievgen Koliesnik
  • , Gernot Kaber
  • , Nadine Nagy
  • , Graham Barlow
  • , Ben A. Falk
  • , Jacqueline K. Reid
  • , Carlos O. Medina
  • , Aviv Hargil
  • , Israel Vlodavsky
  • , Jin-ping Li
  • , Magdiel Perez-Cruz
  • , Sai-Wen Tang
  • , Everett H. Meyer
  • , Lucile E. Wrenshall
  • , James D. Lord
  • , K. Christopher Garcia
  • , Theo D. Palmer
  • , Lawrence Steinman
  • , Gerald T. Nepom
  • Thomas N. Wight, Paul L. Bollyky, Hedwich F. Kuipers

Research output: Contribution to journalArticle

Abstract

FOXP3+ regulatory T cells (Treg) depend on exogenous IL-2 for their survival and function, but circulating levels of IL-2 are low, making it unclear how Treg access this critical resource in vivo. Here, we show that Treg use heparanase (HPSE) to access IL-2 sequestered by heparan sulfate (HS) within the extracellular matrix (ECM) of inflamed central nervous system tissue. HPSE expression distinguishes human and murine Treg from conventional T cells and is regulated by the availability of IL-2. HPSE-/- Treg have impaired stability and function in vivo, including the experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis. Conversely, endowing Treg with HPSE enhances their ability to access HS-sequestered IL-2 and their tolerogenic function in vivo. Together, these data identify novel roles for HPSE and the ECM in immune tolerance, providing new avenues for improving Treg-based therapy of autoimmunity. ### Competing Interest Statement The authors have declared no competing interest.
Original languageAmerican English
Pages (from-to)2023.02.26.529772
JournalbioRxiv (revisions under review at Nature Communications)
StatePublished - 2023

Cite this